Paul Tudor Jones’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Paul Tudor Jones’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,002	Closed	-$7K	–	3091
2023 Q1	$7K	Hold	31,002	–	–	﹤0.01%	2327
2022 Q4	$3K	Hold	31,002	–	–	﹤0.01%	2298
2022 Q3	$33K	Hold	31,002	–	–	﹤0.01%	2197
2022 Q2	$58K	Hold	31,002	–	–	﹤0.01%	1957
2022 Q1	$111K	Buy	31,002 +15,373	+98%	+$75.5K	﹤0.01%	1825
2021 Q4	$135K	Buy	+15,629	New	+$99.4K	﹤0.01%	2214

Other funds holding LHDX

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Paul Tudor Jones's LHDX Position: Q2 2023 in Review

Paul Tudor Jones sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2023, closing a stake of 31,002 shares — an estimated $7K sold.

Paul Tudor Jones first reported a position in LHDX in Q4 2021 and held it in 6 quarters. The position peaked at $135K in Q4 2021. 1 fund tracked by Wall St. Rank holds LHDX as of Q2 2023.

Paul Tudor Jones reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Paul Tudor Jones sold 31,002 Lucira Health, Inc. Common Stock shares in Q2 2023, an estimated $7K.
Paul Tudor Jones first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Paul Tudor Jones's Lucira Health, Inc. Common Stock position peaked at $135K in Q4 2021.
1 fund tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.